The latest data point for PFE's P/S Ratio in Q1'26 stands at 10.94, marking a substantial increase from the previous quarter's 2.46 and representing the highest value in the observed period. Over the timeframe from Q2'23 to Q1'26, the P/S Ratio exhibited an initial upward trend, rising from 2.60 in Q2'23 to a peak of 3.03 in Q2'24, before entering a period of decline and stabilization around 2.20 through Q3'25. The chart shows moderate volatility in the early stages, with a notable dip to 2.17 in Q1'25, followed by a sharp inflection and surge in Q1'26 that suggests potential market revaluation or improved sales expectations for the pharmaceutical sector. Overall, the area chart highlights a predominantly fluctuating pattern with a bullish turn in the most recent period.